Financials
- Market Capitalization 539.57 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnostica e Ricerca
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.25
Rapporto prezzo/fatturato
1.9
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2446 | CSTL Castle Biosciences, Inc. - Common stock | 32.77 USD | -2.18% | -4.32% | +17.75% | +33.13% | 1.00 B USD | ||
| 2532 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 6.05 USD | +0.67% | -5.62% | +16.57% | +211.86% | 890.55 M USD | ||
| 2981 | PRE Prenetics Global Limited - Class A Ordinary Share | 26.25 USD | +1.90% | +17.98% | +34.96% | +232.28% | 442.94 M USD | ||
| 3304 | MYGN Myriad Genetics, Inc. - Common Stock | 3.22 USD | +1.90% | +5.23% | +12.59% | -61.06% | 307.99 M USD |